A recent study has shown that knockdown of CDK9 and a CDK9 inhibitor (LDC000067) could remarkably ameliorate renal fibrosis by blocking the phosphorylation of the Smad3 linker (Thr179) (Qu et al., 2015). The gene discussed is CDK9; the disease is renal fibrosis.